US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.1614

-0.0090-5.28%

Post-market: 0.1595-0.0019-1.18%19:59 EDT

Volume:18.16M

Turnover:3.14M

Market Cap:10.20M

PE:-0.10

High:0.1724

Open:0.1718

Low:0.1570

Close:0.1704

52wk High:3.05

52wk Low:0.1512

Shares:63.18M

Float Shares:56.90M

Volume Ratio:0.64

T/O Rate:31.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6597

EPS(LYR):-2.7356

ROE:-7446.11%

ROA:-110.67%

PB:-5.78

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million

Medicus Pharma Ltd expected to post a loss of 19 cents a share - Earnings Preview

Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)

Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma

Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc

THOMSON REUTERS

Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events

THOMSON REUTERS

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines

Medicus Pharma Expands ATM Equity Program for Funding

BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents

Medicus Pharma Ltd - May Offer and Sell Common Shares up to $50 Mln Aggregate Through Agents - SEC Filing

THOMSON REUTERS

Medicus Pharma initiated with a Buy at Roth Capital

Medicus Pharma announces annual general and special shareholder meeting

Medicus Pharma Is Maintained at Buy by D. Boral Capital

Medicus Pharma submits ODD application to U.S. FDA for SkinJect

Medicus Pharma seeks FDA orphan drug designation for SkinJect in Gorlin syndrome

Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy

EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline

Benzinga_recent_news

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/MDCX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":0.1614,"timestamp":1789070400000,"preClose":0.1704,"halted":0,"volume":18164197,"hourTrading":{"tag":"盘后","latestPrice":0.159501,"preClose":0.1614,"latestTime":"19:59 EDT","volume":887286,"amount":142298.89452,"timestamp":1789084777801,"change":-0.001899,"changeRate":-0.011766,"amplitude":0.043371},"delay":0,"changeRate":-0.05281690140845075,"floatShares":56901000,"shares":63180610,"eps":-1.659689,"marketStatus":"Not Yet Opened","change":-0.009,"latestTime":"09-10 16:00:00 EDT","open":0.1718,"high":0.1724,"low":0.157,"amount":3142930.2997254203,"amplitude":0.090376,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.659689,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":0,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":0.1704,"preHourTrading":{"tag":"盘前","latestPrice":0.17,"preClose":0.1704,"latestTime":"09:29 EDT","volume":6612869,"amount":1170465.11629152,"timestamp":1789046999371,"change":-0.0004,"changeRate":-0.002347,"amplitude":0.158451},"postHourTrading":{"tag":"盘后","latestPrice":0.159501,"preClose":0.1614,"latestTime":"19:59 EDT","volume":887286,"amount":142298.89452,"timestamp":1789084777801,"change":-0.001899,"changeRate":-0.011766,"amplitude":0.043371},"volumeRatio":0.643152},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":56901000,"roa":"-110.67%","roe":"-7446.11%","lyrEps":-2.735593,"volumeRatio":0.643152,"shares":63180610,"dividePrice":0,"high":0.1724,"amplitude":0.090376,"preClose":0.1704,"low":0.157,"week52Low":0.1512,"pbRate":"-5.78","week52High":3.05,"institutionHeld":0,"latestPrice":0.1614,"eps":-1.659689,"divideRate":0,"volume":18164197,"delay":0,"ttmEps":-1.659689,"open":0.1718,"prevYearClose":1.53,"prevWeekClose":0.172,"prevMonthClose":0.2618,"prevQuarterClose":0.4463,"fiveDayClose":0.2599,"twentyDayClose":0.3311,"sixtyDayClose":0.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"MDCX","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2026-05-14","symbol":"MDCX","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-03-25","symbol":"MDCX","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.82},{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post-Mkt","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785297600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-09-09","current":-0.097247,"percent":1,"low":-3.23298,"twenty":-2.167912,"median":-0.736109,"eighty":-0.336268,"high":-0.189555,"avg":-1.083424,"sd":0.948792,"marketCap":10740703},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-13","current":-0.412761,"twenty":-2.835443,"median":-1.263181,"eighty":-0.891018,"marketCap":14756541},{"date":"2026-03-20","current":-0.412761,"twenty":-2.825864,"median":-1.220048,"eighty":-0.847322,"marketCap":14756541},{"date":"2026-03-27","current":-0.387698,"twenty":-2.82079,"median":-1.201563,"eighty":-0.836077,"marketCap":18330934},{"date":"2026-04-02","current":-0.349652,"twenty":-2.811211,"median":-1.179996,"eighty":-0.820403,"marketCap":16532085},{"date":"2026-04-10","current":-0.367967,"twenty":-2.792337,"median":-1.125793,"eighty":-0.786136,"marketCap":17398052},{"date":"2026-04-17","current":-0.250001,"twenty":-2.775573,"median":-1.109135,"eighty":-0.744685,"marketCap":11820441},{"date":"2026-04-24","current":-0.276475,"twenty":-2.764797,"median":-1.099378,"eighty":-0.508201,"marketCap":13072156},{"date":"2026-05-01","current":-0.235266,"twenty":-2.75402,"median":-1.088841,"eighty":-0.417566,"marketCap":11123732},{"date":"2026-05-08","current":-0.277717,"twenty":-2.74923,"median":-1.069002,"eighty":-0.412761,"marketCap":13130880},{"date":"2026-05-15","current":-0.393186,"twenty":-2.733353,"median":-1.041354,"eighty":-0.401798,"marketCap":18590424},{"date":"2026-05-22","current":-0.308017,"twenty":-2.714637,"median":-1.024243,"eighty":-0.38811,"marketCap":15777036},{"date":"2026-05-29","current":-0.354651,"twenty":-2.703729,"median":-1.018593,"eighty":-0.376126,"marketCap":18165658},{"date":"2026-06-05","current":-0.402361,"twenty":-2.691755,"median":-0.976444,"eighty":-0.374724,"marketCap":20609444},{"date":"2026-06-12","current":-0.35842,"twenty":-2.672597,"median":-0.968141,"eighty":-0.372398,"marketCap":18358733},{"date":"2026-06-18","current":-0.378775,"twenty":-2.63428,"median":-0.962395,"eighty":-0.367967,"marketCap":19401342},{"date":"2026-06-26","current":-0.492235,"twenty":-2.63428,"median":-0.955088,"eighty":-0.371628,"marketCap":25212882},{"date":"2026-07-02","current":-0.442458,"twenty":-2.59471,"median":-0.94132,"eighty":-0.37203,"marketCap":22663265},{"date":"2026-07-10","current":-0.467347,"twenty":-2.543128,"median":-0.915037,"eighty":-0.3732,"marketCap":23938074},{"date":"2026-07-17","current":-0.449095,"twenty":-2.516028,"median":-0.871896,"eighty":-0.374395,"marketCap":23003214},{"date":"2026-07-24","current":-0.424981,"twenty":-2.511859,"median":-0.846653,"eighty":-0.374627,"marketCap":21768066},{"date":"2026-07-31","current":-0.290474,"twenty":-2.411802,"median":-0.843141,"eighty":-0.371929,"marketCap":14878433},{"date":"2026-08-07","current":-0.34025,"twenty":-2.326336,"median":-0.835949,"eighty":-0.363051,"marketCap":17428051},{"date":"2026-08-14","current":-0.353971,"twenty":-2.282561,"median":-0.821824,"eighty":-0.360424,"marketCap":20056990},{"date":"2026-08-21","current":-0.30351,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"marketCap":17197762},{"date":"2026-08-28","current":-0.298604,"twenty":-2.178335,"median":-0.778989,"eighty":-0.346389,"marketCap":16919767},{"date":"2026-09-04","current":-0.190112,"twenty":-2.172081,"median":-0.757549,"eighty":-0.339549,"marketCap":10772294},{"date":"2026-09-09","current":-0.189555,"twenty":-2.167912,"median":-0.736109,"eighty":-0.336268,"marketCap":10740703}],"updateTime":1789109608823},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635772644","title":"Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772644?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":"Company Advances SkinJect and Teverelix Clinical Programs While Strengthening Financing Flexibility and Expanding Strategic Development InitiativesPHILADELPHIA, May  14, 2026  (GLOBE NEWSWIRE) -- Medi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295423/0/en/Medicus-Pharma-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCC","BK4585","BK4104","LU1169589451.USD","MDCX","BK4139","BK4567","MNA","PD","LU1169590202.USD","BK4023","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635237397","title":"Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635237397","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635237397?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:12","pubTimestamp":1778789556,"startTime":"0","endTime":"0","summary":"Medicus Pharma posted a net loss of USD 9.04 million for the quarter ended March 31, 2026, widening from the prior-year period; loss per share narrowed to USD 0.31.Operating loss widened to USD 8.6 million as total operating expenses climbed 67.7% to USD 8.6 million.General and administrative expense rose 88.9% to USD 5.89 million, while R&D increased 34.8% to USD 2.7 million.Phase 2 SKNJCT-003 SkinJect dataset showed 73% clinical clearance in the 200-g cohort at Day 57, with FDA “study may proceed” clearance received to start a Phase 2b dose-optimization study of Teverelix in advanced prostate cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL1mMtjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467553","title":"Medicus Pharma Ltd  expected to post a loss of 19 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467553","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467553?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:02","pubTimestamp":1778274128,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd  expected to post a loss of19cents a share - Earnings Preview Medicus Pharma Ltd MDCX.OQ MDCX.O is expected to  show no change in quarterly revenue when it reports  results on May 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633017877","title":"Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633017877","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633017877?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:50","pubTimestamp":1778179812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-zevra-therapeutics-zvra-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-zevra-therapeutics-zvra-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","ZVRA","BK4007","BK4112","BK4585","LABU","BK4139","BK4588","LU0029874061.USD","BLSX","BLSG","MDCX","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187782","title":"Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187782?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:32","pubTimestamp":1778067154,"startTime":"0","endTime":"0","summary":"Medicus Pharma reported results from a pre-specified expanded Phase 2 analysis of SKNJCT-003 testing its doxorubicin microneedle array for nodular basal cell carcinoma, adding to previously disclosed topline data from broader randomized enrollment.Updated review showed a clearer dose-response signal, with higher-dose treatment delivering the strongest overall clearance pattern versus device-only control.Separation versus control strengthened over follow-up, supporting a drug-driven effect rather than a short-lived device response.Safety profile remained favorable, with no drug-related serious adverse events reported and no signs of systemic doxorubicin toxicity.Dataset is being positioned to support end-of-Phase 2 talks with FDA on a registration path, including selection of dose and target patient population.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL10vV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4112","NDAQ","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP","BK4139","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4585","MDCX","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187796","title":"Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187796?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J05G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187791","title":"Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187791?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067050,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J05G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180180","title":"Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180180","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633180180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":"200g Cohort Achieves 55% Complete Response at Day 57 Emerging as Registrational Grade Lead RegimenPHILADELPHIA, May  06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288692/0/en/Medicus-Pharma-Announces-Results-from-Pre-Specified-Expanded-Phase-2-SKNJCT-003-Data-Analysis-Demonstrating-Positive-Dose-Response.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395692","title":"Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395692?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:30","pubTimestamp":1777289400,"startTime":"0","endTime":"0","summary":"Builds Support for Accelerated Access to SkinJect for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April  27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281511/0/en/Medicus-Pharma-CEO-meets-with-lawmakers-on-Energy-Commerce-Committee-on-Capitol-Hill.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BK4139","BK4023","BK4567","BK4104","IND","BCC","MNA","LU1169590202.USD","MDCX","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630679803","title":"Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2630679803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630679803?lang=en_us&edition=fundamental","pubTime":"2026-04-25 20:15","pubTimestamp":1777119332,"startTime":"0","endTime":"0","summary":"Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Medicus Pharma Ltd. The associated price target was lowered to $2.00. Jas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balancing-pipeline-potential-and-funding-risk-justifying-a-buy-rating-on-medicus-despite-extended-timelines-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balancing-pipeline-potential-and-funding-risk-justifying-a-buy-rating-on-medicus-despite-extended-timelines-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630487806","title":"Medicus Pharma Expands ATM Equity Program for Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2630487806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630487806?lang=en_us&edition=fundamental","pubTime":"2026-04-25 06:21","pubTimestamp":1777069305,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has provided an announcement. On April 23, 2026, Medicus Pharma Ltd. amended its equity distribution arrangement wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-expands-atm-equity-program-for-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-expands-atm-equity-program-for-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4215","MDCX","BK4139","EQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629869263","title":"BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents","url":"https://stock-news.laohu8.com/highlight/detail?id=2629869263","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629869263?lang=en_us&edition=fundamental","pubTime":"2026-04-24 06:06","pubTimestamp":1776981998,"startTime":"0","endTime":"0","summary":"BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents April 23  - Medicus Pharma Ltd MDCX.O:MEDICUS PHARMA LTD - MAY OFFER AND SELL COMMON SHARES UP TO $50 MILLION AGGREGATE THROUGH AGENTS - SEC FILINGSource text: [ID:n0001062993-26-002127]Further company coverage: MDCX.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN41616T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629866189","title":"Medicus Pharma Ltd - May Offer and Sell Common Shares up to $50 Mln Aggregate Through Agents - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629866189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629866189?lang=en_us&edition=fundamental","pubTime":"2026-04-24 05:12","pubTimestamp":1776978747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN41616T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629364550","title":"Medicus Pharma initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2629364550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629364550?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:53","pubTimestamp":1776772435,"startTime":"0","endTime":"0","summary":"Roth Capital initiated coverage of Medicus Pharma (MDCX) with a Buy rating and $9 price target The firm projects growing revenue from the company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629808737","title":"Medicus Pharma announces annual general and special shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629808737","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629808737?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:05","pubTimestamp":1776765913,"startTime":"0","endTime":"0","summary":"Medicus Pharma set annual general and special shareholder meeting for June 3, 2026 in Toronto, Ontario.Shareholders will vote on appointment of KPMG as auditor, including authorization to set auditor remuneration.Ballot includes election of nine director nominees for the coming year.Special resolution seeks authority for board to consolidate common shares at a ratio up to 50-to-1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL7fv5BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628231107","title":"Medicus Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2628231107","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628231107?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:48","pubTimestamp":1776689280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MDCX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 20, 2026 08:48 ET (12:48 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628203704","title":"Medicus Pharma submits ODD application to U.S. FDA for SkinJect","url":"https://stock-news.laohu8.com/highlight/detail?id=2628203704","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628203704?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:35","pubTimestamp":1776425750,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) announced the submission of an Orphan Drug Designation, ODD, application to the U.S. Food and Drug Administration for SkinJec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-submits-odd-application-to-u-s-fda-for-skinject-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-submits-odd-application-to-u-s-fda-for-skinject-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4183","IE0009354923.USD","BK4588","LABU","MDCX","BK4139","ODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628039742","title":"Medicus Pharma seeks FDA orphan drug designation for SkinJect in Gorlin syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2628039742","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628039742?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:30","pubTimestamp":1776425436,"startTime":"0","endTime":"0","summary":"Medicus Pharma submitted an orphan drug designation application to FDA for SkinJect to treat basal cell carcinoma in patients with Gorlin Syndrome.Filing targets an orphan indication estimated at about 11,000 US patients.Orphan designation, if granted, could support a faster regulatory path for SkinJect and provide 7 years of US market exclusivity on approval.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL5V1RSV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014005.SGD","NDAQ","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","LU0314104364.USD","MDCX","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","BK4112","BK4588","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627280938","title":"Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2627280938","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627280938?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:36","pubTimestamp":1776260171,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has shared an announcement. Medicus Pharma will present new Phase I data on its investigational long-acting GnRH ant...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-showcases-long-acting-teverelix-data-targets-precision-endometriosis-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-showcases-long-acting-teverelix-data-targets-precision-endometriosis-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627286039","title":"EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2627286039","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627286039?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:16","pubTimestamp":1776251760,"startTime":"0","endTime":"0","summary":"Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/15/Healthcare-Scientist-Using-Tablet-In-Lab.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/15/Healthcare-Scientist-Using-Tablet-In-Lab.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51826062/exclusive-penny-stock-medicus-pharma-findings-support-potential-in-womens-health-pipeline","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/04/51826062/exclusive-penny-stock-medicus-pharma-findings-support-potential-in-womens-health-pipeline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":105,"code":"91000000","status":"200"}]}}